2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on …
Abstract Aim The “2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure”
replaces the “2013 ACCF/AHA Guideline for the Management of Heart Failure” and the …
replaces the “2013 ACCF/AHA Guideline for the Management of Heart Failure” and the …
The use of diuretics in heart failure with congestion—a position statement from the Heart Failure Association of the European Society of Cardiology
W Mullens, K Damman, VP Harjola… - European journal of …, 2019 - Wiley Online Library
The vast majority of acute heart failure episodes are characterized by increasing symptoms
and signs of congestion with volume overload. The goal of therapy in those patients is the …
and signs of congestion with volume overload. The goal of therapy in those patients is the …
KDIGO 2021 clinical practice guideline for the management of glomerular diseases
BH Rovin, SG Adler, J Barratt, F Bridoux… - Kidney …, 2021 - kidney-international.org
Glomerular disease, be it primary or secondary, occurring in the setting of systemic
autoimmune diseases, infections, drugs, or malignancy, affects individuals of all ages. In …
autoimmune diseases, infections, drugs, or malignancy, affects individuals of all ages. In …
Combining loop with thiazide diuretics for decompensated heart failure: the CLOROTIC trial
JC Trullàs, JL Morales-Rull, J Casado… - European heart …, 2023 - academic.oup.com
Aims To evaluate whether the addition of hydrochlorothiazide (HCTZ) to intravenous
furosemide is a safe and effective strategy for improving diuretic response in acute heart …
furosemide is a safe and effective strategy for improving diuretic response in acute heart …
Empagliflozin in heart failure: diuretic and cardiorenal effects
Background: Sodium-glucose cotransporter-2 inhibitors improve heart failure–related
outcomes. The mechanisms underlying these benefits are not well understood, but diuretic …
outcomes. The mechanisms underlying these benefits are not well understood, but diuretic …
Diuretic Therapy for Patients With Heart Failure: JACC State-of-the-Art Review
Expansion of extracellular fluid volume is central to the pathophysiology of heart failure.
Increased extracellular fluid leads to elevated intracardiac filling pressures, resulting in a …
Increased extracellular fluid leads to elevated intracardiac filling pressures, resulting in a …
Renal and cardiovascular effects of SGLT2 inhibition in combination with loop diuretics in patients with type 2 diabetes and chronic heart failure: the RECEDE-CHF …
Background: SGLT2 (sodium-glucose cotransporter-2) inhibitors improve heart failure–
associated outcomes in patients with type 2 diabetes. In patients with heart failure, SGLT2 …
associated outcomes in patients with type 2 diabetes. In patients with heart failure, SGLT2 …
KDIGO 2021 clinical practice guideline for the management of blood pressure in chronic kidney disease
The original KDIGO Clinical Practice Guideline for the Management of Blood Pressure in
Chronic Kidney Disease in the chronic kidney disease (CKD) population not receiving …
Chronic Kidney Disease in the chronic kidney disease (CKD) population not receiving …
Diuretic treatment in heart failure
Diuretic Treatment in Heart Failure | New England Journal of Medicine Skip to main content The
New England Journal of Medicine homepage Advanced Search SEARCH SPECIALTIES …
New England Journal of Medicine homepage Advanced Search SEARCH SPECIALTIES …
Diuretic strategies for loop diuretic resistance in acute heart failure: the 3T trial
ZL Cox, R Hung, DJ Lenihan, JM Testani - Heart Failure, 2020 - jacc.org
Objectives This study compared combination diuretic strategies in acute heart failure (AHF)
complicated by diuretic resistance (DR). Background Combination diuretic regimens to …
complicated by diuretic resistance (DR). Background Combination diuretic regimens to …